Surveillance Data Use Through the Fleming Fund: Informing Action on Antimicrobial Resistance in Low- and Middle-Income Countries.

Authors

Archie Drake, Alesia Ofori, Amy Rahmadanti, Ankur Gupta-Wright, Areeya Disratthakit, Ayodele Majekodunmi, Benjamin Kissi Sasu, N Claire Gordon, Claudia Parry, Collins Mitambo, Deborah Nanjebe, Desrina Sitompul, Didem Torumkuney, Evelyn Wesangula, Freddy Eric Kitutu, Heidi Hopkins, Jacob Wildfire, Japheth A Opintan, Jennifer Armitage, Joseph Sam Kanu, Kate Macintyre, Kriti Khurana, Lamiaa Shehata, Manish Pathak, Megha Raj Banjara, Milena von Und Zur Mühlen, Muhammad Taimoor Kayani, Muhammad Usman Zaheer, Mwapu Ndahi, Nandini Shetty, Nicholas Feasey, Nigel French, Nimesh Poudyal, Nure Alam Siddiky, Paul Turner, Pem Chuki, Qadeer Ahsan, Rebecca Maudling, Ritu Amatya, Satyajit Sarkar, Syed Abbas, Tamalee Roberts, Tauqeer Mustafa, Tim Shorten, Titha Dzowela, Toby Leslie, Tochi Okwor, Yu Nandar Aung

Published in

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Volume 83. Issue Supplement_1. Pages S25-S36. Oct 19, 2026.

Abstract

Drawing on the Fleming Fund's work to strengthen antimicrobial resistance (AMR) surveillance across Africa and Asia during 2018-2026, this article provides one of the first syntheses of AMR surveillance data use in low- and middle-income countries.
A participatory synthesis for narrative review was conducted to summarize experience across administrative levels (facility, subnational, national, and regional).
Data use was most evident at the facility level, in human health systems where resistance patterns, antimicrobial use, and clinical data increasingly informed antimicrobial stewardship, infection prevention and control, and other quality improvement initiatives. Data use in other sectors required different approaches. At the national level, Fleming Fund investments were associated with revisions of treatment guidelines, updates of essential medicines lists, and regulatory measures, primarily through improved governance and policy communities. Regional platforms supported member country data use at the national level. Subnational data use was undertaken in countries with decentralized health systems. Across levels, data use pathways driven by local priorities helped surveillance inform action.
Fleming Fund experience suggests that surveillance is more likely to inform action when data use is built into system design. Continued investment will be needed if AMR surveillance is to improve policy and practice in low- and middle-income countries.

PMID:
42895836
Bibliographic data and abstract were imported from PubMed on 20 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.